Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 25 of 31

COMPLETED NA

Buprenorphine Disposition and CYP3A

NCT01576575

COMPLETED Phase 2

Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV

NCT01093651

COMPLETED NA

Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH

NCT01137110

COMPLETED Phase 2

Does More Practice Improve Arm Movement After Stroke?

NCT01146379

COMPLETED Phase 1

Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)

NCT01001143

COMPLETED

Heart Function in HIV-Negative Children Exposed to HIV and HAART

NCT01107834

COMPLETED

Reversal of Obesity Cardiomyopathy

NCT01372397

COMPLETED NA

Sugar-replacement Sweeteners, and Blood Sugar Control

NCT01128829

COMPLETED

Fat Perception in Humans (09-0873)

NCT01128400

COMPLETED NA

The Effectiveness of a Fall Prevention Program

NCT01833182

TERMINATED Phase 1

IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)

NCT01027923

COMPLETED Phase 1

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

NCT01026987

COMPLETED NA

A Multicenter Prospective Study of Quality of Life in Adult Scoliosis

NCT00854828

COMPLETED Phase 1

Azacitidine and Lenalidomide for Acute Myeloid Leukemia

NCT01016600

COMPLETED

Comparison of Body Composition & Weight Change in Users of Progestin-only Contraception During the First Year of Use

NCT01579773

COMPLETED

This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy

NCT01098708

COMPLETED NA

A Randomized Prospective Trial of Total Knee Arthroplasty Options Comparing Standard Knee Cutting Guides and MRI Generated Patient Specific Custom Cutting Guides

NCT01072019

COMPLETED Phase 3

Combining Exercise and Cognitive Training to Improve Everyday Function

NCT01603784

COMPLETED NA

The Bladder Flap at Cesarean Section: A Randomized Controlled Trial

NCT00918996

TERMINATED NA

Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children

NCT00955877

COMPLETED

Biomarkers of Cardiometabolic Risk in Children Treated With Antipsychotics: A Preliminary Study of Direct Measures

NCT00894738

COMPLETED NA

Depression and Self-care in Heart Failure

NCT01028625

COMPLETED NA

Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients

NCT01309724

COMPLETED

BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor

NCT01124461

COMPLETED Phase 4

Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis

NCT01060020

COMPLETED NA

The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy

NCT01027715

COMPLETED

Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery

NCT01067209

COMPLETED Phase 2

Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia

NCT01005576

COMPLETED

Association Between a Mother's Exposure to "Strep Throat" and Her Baby's Developing Heart Disease

NCT01603732

TERMINATED NA

Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study

NCT01162382

COMPLETED Phase 1

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

NCT01668134

COMPLETED Phase 1

Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant

NCT00986804

COMPLETED

Glucose Homeostasis Pre and Post Bariatric Surgery

NCT00981500

COMPLETED NA

Total Knee Arthroplasty (TKA) Cemented Versus Cementless Tibial Prosthesis Study

NCT01041937

COMPLETED NA

Integrating Cancer Control Referrals and Navigators Into United Way 211 Missouri

NCT01027741

TERMINATED Phase 1

Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer

NCT00892242

TERMINATED NA

Comparing Previously Placed Nephrostomy Tract (NT) Versus Single Stage Percutaneous Nephrolithotomy (PCNL)

NCT00907946

COMPLETED

Prospective Memory in Parkinson's Disease

NCT00913640

COMPLETED Phase 2

Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer

NCT01060007

COMPLETED Phase 3

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

NCT00790335

COMPLETED NA

Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up

NCT00929084

TERMINATED NA

A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation

NCT00913159

COMPLETED NA

Alfentanil: Simultaneous Testing Pilot

NCT01008059

COMPLETED Phase 4

Community Care for Croup (RCT)

NCT01042145

COMPLETED Phase 1

Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer

NCT00807781

COMPLETED Phase 1

Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function

NCT00949663

COMPLETED NA

Childhood Obesity Treatment: A Maintenance Approach

NCT00759746

COMPLETED NA

Energy Expenditure Responses to Acute Exercise in Older Women (Calorie Expenditure and Exercise)

NCT00988299

COMPLETED Early Phase 1

iNOS With Positron Emission Tomography (PET) in Cellular Inflammation.

NCT01066637

COMPLETED

Taste Perception Pre and Post Bariatric Surgery

NCT01536197

← Previous Page 25 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.